Atea Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 17.1% | 17.1% | 15.7% |
| FY2022 | -18.1% | -18.1% | -17.4% |
| FY2023 | -24.5% | -24.5% | -22.9% |
| FY2024 | -38.4% | -38.4% | -36.2% |
| FY2025 | -57.5% | -57.5% | -50.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 17.1% | 17.1% | 15.7% |
| FY2022 | -18.1% | -18.1% | -17.4% |
| FY2023 | -24.5% | -24.5% | -22.9% |
| FY2024 | -38.4% | -38.4% | -36.2% |
| FY2025 | -57.5% | -57.5% | -50.2% |